These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15664817)

  • 1. Generation of a new class of hNK(2) receptor ligands using the 'fragment approach'.
    D'Andrea P; Porcelloni M; Madami A; Patacchini R; Altamura M; Fattori D
    Bioorg Med Chem Lett; 2005 Feb; 15(3):585-8. PubMed ID: 15664817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational rigidity versus flexibility in a novel peptidic neurokinin A receptor antagonist.
    Pavone V; Lombardi A; Maggi CA; Quartara L; Pedone C
    J Pept Sci; 1995; 1(4):236-40. PubMed ID: 9223001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha,alpha-Cyclic aminoacids as useful scaffolds for the preparation of hNK(2) receptor antagonists.
    Sisto A; Altamura M; Cardinali F; D'Andrea P; Rossi C; Fattori D
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4841-4. PubMed ID: 17604625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular modelling and drug design: neurokinin receptor antagonism].
    Boudon A; Jacoby E; Michel A
    J Pharm Belg; 1997; 52(2):103. PubMed ID: 9296954
    [No Abstract]   [Full Text] [Related]  

  • 5. New monocyclic and acyclic hNK-2 antagonists retaining the beta-turn feature. X-ray and molecular modelling studies.
    Altamura M; Dapporto P; Fedi V; Giolitti A; Guerri A; Guidi A; Maggi CA; Paoli P; Rossi P
    Acta Crystallogr B; 2006 Oct; 62(Pt 5):889-96. PubMed ID: 16983169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists.
    Hoffmann T; Bös M; Stadler H; Schnider P; Hunkeler W; Godel T; Galley G; Ballard TM; Higgins GA; Poli SM; Sleight AJ
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1362-5. PubMed ID: 16332435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
    Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
    Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first de novo-designed antagonists of the human NK(2) receptor.
    Ali MA; Bhogal N; Findlay JB; Fishwick CW
    J Med Chem; 2005 Sep; 48(18):5655-8. PubMed ID: 16134933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel triple neurokinin receptor antagonist CS-003 strongly inhibits neurokinin related responses.
    Tsuchida H; Takahashi S; Nosaka E; Mukaiyama O; Yamashita M; Morimoto K
    Eur J Pharmacol; 2008 May; 586(1-3):306-12. PubMed ID: 18353309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid receptor ligands. Part 4: 4'-amido bioisosteric ligands selective for the thyroid hormone receptor beta.
    Li YL; Litten C; Koehler KF; Mellström K; Garg N; Garcia Collazo AM; Färnegård M; Grynfarb M; Husman B; Sandberg J; Malm J
    Bioorg Med Chem Lett; 2006 Feb; 16(4):884-6. PubMed ID: 16303304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel, potent and orally active series of gamma-lactams as selective NK1 antagonists.
    Paliwal S; Reichard GA; Shah S; Wrobleski ML; Wang C; Stengone C; Tsui HC; Xiao D; Duffy RA; Lachowicz JE; Nomeir AA; Varty GB; Shih NY
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4168-71. PubMed ID: 18547807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands.
    Rivara S; Lodola A; Mor M; Bedini A; Spadoni G; Lucini V; Pannacci M; Fraschini F; Scaglione F; Sanchez RO; Gobbi G; Tarzia G
    J Med Chem; 2007 Dec; 50(26):6618-26. PubMed ID: 18052314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-affinity relationship studies in NK1 receptor ligands based on azole-fused quinolinecarboxamide moieties.
    Cappelli A; Giuliani G; Anzini M; Riitano D; Giorgi G; Vomero S
    Bioorg Med Chem; 2008 Jul; 16(14):6850-9. PubMed ID: 18554914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fused tricyclic pyrrolizinones that exhibit pseudo-irreversible blockade of the NK1 receptor.
    Morriello GJ; Chicchi G; Johnson T; Mills SG; Demartino J; Kurtz M; Tsao KL; Zheng S; Tong X; Carlson E; Townson K; Wheeldon A; Boyce S; Collinson N; Rupniak N; Devita RJ
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5925-32. PubMed ID: 20729082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and structure-activity relationship studies of hexahydropyrazinoquinolines as a novel class of potent and selective dopamine receptor 3 (D3) ligands.
    Ji M; Chen J; Ding K; Wu X; Varady J; Levant B; Wang S
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1701-5. PubMed ID: 15745825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-tryptophan urea amides as NK1/NK2 dual antagonists.
    Qi H; Shah SK; Cascieri MA; Sadowski SJ; MaCcoss M
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2259-62. PubMed ID: 9873524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonists at the neurokinin receptors--recent patent literature.
    Giardina GA; Gagliardi S; Martinelli M
    IDrugs; 2003 Aug; 6(8):758-72. PubMed ID: 12917772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK₁/NK₃ antagonists.
    Bissantz C; Bohnert C; Hoffmann T; Marcuz A; Schnider P; Malherbe P
    J Med Chem; 2012 Jun; 55(11):5061-76. PubMed ID: 22574973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
    Wakabayashi K; Miyachi H; Hashimoto Y; Tanatani A
    Bioorg Med Chem; 2005 Apr; 13(8):2837-46. PubMed ID: 15781394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.
    Lavey BJ; Kozlowski JA; Hipkin RW; Gonsiorek W; Lundell DJ; Piwinski JJ; Narula S; Lunn CA
    Bioorg Med Chem Lett; 2005 Feb; 15(3):783-6. PubMed ID: 15664857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.